デフォルト表紙
市場調査レポート
商品コード
1735879

世界の臨床意思決定支援システム(CDSS)市場、2024-2030年

Clinical Decision Support System Market, Global, 2024-2030


出版日
ページ情報
英文 54 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.00円
世界の臨床意思決定支援システム(CDSS)市場、2024-2030年
出版日: 2025年05月09日
発行: Frost & Sullivan
ページ情報: 英文 54 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

AI統合が臨床成果の改善を可能にし、変革的成長を牽引

効果的な集団健康管理への注目が高まる中、医療機関は次世代の臨床意思決定支援ツールの導入を促し、市場成長を牽引しています。医療システムは、臨床の質と効率に関する重大な課題に直面し続けており、臨床意思決定支援システム(CDSS)の導入への注目が高まっています。これらのツールは、病院と在宅医療の両方の環境において、早期診断とタイムリーで的確な臨床介入を促進します。また、患者の合併症の予防にも役立つため、入院やICUへの入室など、コストのかかる介入の必要性を減らすことができます。生成AIや対話型AIを含む人工知能(AI)と機械学習の技術的進歩は、CDSSソリューションの継続的なイノベーションを後押ししています。

Frost & Sullivanのレポートは、世界のCDSS市場の概要を提供し、意思決定エビデンス/プロトコル、意思決定ワークフロー、意思決定アナリティクス、意思決定デリバリーの各アプリケーションセグメントについて、収益予測を含む詳細な分析を提供しています。また、この市場の促進要因と抑制要因を検証し、この分野の変化から生まれる市場企業や関係者が活用すべき機会を特定しています。基準年は2024年、予測期間は2025年から2030年です。

収益予測

基準年である2024年の収益推定額は107億5,280万米ドルで、2024年から2030年までの調査期間のCAGRは7.6%です。

主な競合企業

  • Optum
  • EBSCO
  • Elsevier
  • Hearst Health
  • Merative
  • Medicomp Systems
  • Wolters Kluwer
  • RethinkFirst
  • Glass Health
  • UNORK
  • Premier Inc. (STANTON HEALTH)
  • Getinge
  • Motive Medical Intelligence
  • athenahealth
  • EvidenceCare
  • HCA Healthcare
  • MEDITECH
  • eClinicalWorks
  • Wolters Kluwer
  • RIMIDI
  • Inovalon
  • Vizio
  • Flatiron Health (Roche)
  • Medecision
  • MCG Health
  • Epic
  • Medical Informatics Corp.
  • Medtronic
  • Oracle Health
  • Philips Healthcare
  • GE Healthcare
  • Stat Pearls

目次

成長機会:調査範囲

  • 分析範囲
  • 用途別セグメンテーション
  • 地域別セグメンテーション
  • 主要ベンダータイプ

成長環境:CDSSにおけるトランスフォーメーション

  • なぜ成長が難しくなっているのか?
  • The Strategic Imperative 8
  • CDSS業界に対する戦略的インペラティブトップ3の影響

CDSSにおけるエコシステム

  • 競合環境
  • 主な競合企業

CDSSにおける成長ジェネレーター

  • CDSSの進化
  • 主なユースケース
  • 主な市場動向
  • 主な課題と価値提案
  • 消費者の声:CDSSにおけるAIの統合
  • CDSSにおける潜在的なGenAIのユースケース
  • AIによるベンダーの価値提案
  • 規制シナリオ:CDSSに対するFDAのアプローチ
  • 成長指標
  • 成長促進要因
  • 成長抑制要因
  • 予測に関する考察
  • 収益予測
  • アプリケーション別の収益予測
  • 収益予測分析
  • 価格動向と予測分析
  • 地域別の収益予測
  • CDSSソリューションの魅力度分析
  • 地域の魅力度ランキングとマッピング
  • 地域別の収益予測分析
  • 収益シェア:競合ヒートマップ
  • 収益シェア:競合ヒートマップ分析
  • 企業スポットライト

成長ジェネレーター:意思決定エビデンス/プロトコル

  • 成長指標
  • 収益予測
  • 地域別の収益予測
  • 予測分析

成長ジェネレーター:意思決定アナリティクス

  • 成長指標
  • 収益予測
  • 地域別の収益予測
  • 予測分析

成長ジェネレーター:意思決定ワークフロー

  • 成長指標
  • 収益予測
  • 地域別の収益予測
  • 予測分析

成長ジェネレーター:意思決定デリバリー

  • 成長指標
  • 収益予測
  • 地域別の収益予測
  • 予測分析

成長機会ユニバース

  • 成長機会1:CDSSにおけるAI
  • 成長機会2:重症患者向けリアルタイムデータ
  • 成長機会3:在宅治療向けポイントオブケアCDSS

付録と次のステップ

  • 成長機会のメリットとインパクト
  • 次のステップ
  • 添付リスト
  • 免責事項
目次
Product Code: KB09-48

AI Integration is Driving Transformational Growth by Enabling Improvements in Clinical Outcomes

The increasing focus on effective population health management is prompting healthcare organizations to adopt next-generation clinical decision support tools that drive market growth. Healthcare systems continue to face significant clinical quality and efficiency challenges, leading to a heightened focus on implementing clinical decision support systems (CDSS). These tools facilitate early diagnosis and timely, precise clinical interventions in both hospital and home-based healthcare settings. They also help prevent complications in patient conditions, thereby reducing the need for costly interventions such as hospital readmissions and ICU admissions. Technological advancements in artificial intelligence (AI) and machine learning, including generative AI and conversational AI, are boosting ongoing innovation in CDSS solutions.

This Frost & Sullivan report provides an overview of the global CDSS market, offering a detailed analysis, including a revenue forecast, for each application segment, namely, decision evidence/protocols, decision workflow, decision analytics, and decision delivery. The report also examines the factors driving and restraining this market and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2024, and the forecast period is from 2025 to 2030.

Revenue Forecast

The revenue estimate for the base year 2024 is $10,752.8 million, with a CAGR of 7.6% for the study period from 2024 to 2030.

Scope of Analysis

  • Clinical decision support (CDS) provides clinicians and healthcare staff with knowledge and person-specific information that helps them improve clinical decisions and enhance patient healthcare.
  • A clinical decision support system (CDSS) is a broad concept with many definitions that are used variably. It encompasses a variety of tools to enhance decision-making in the clinical workflow.
  • CDSS includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that consist of the electronic health record (EHR) and are maintained by an IT platform.
  • This report delivers a detailed analysis of the CDSS market and its applications, specifically, decision evidence/protocols, decision workflow, decision analytics, and decision delivery.
  • The report analyzes industry challenges, drivers, and restraints, and offers a revenue forecast for each application area.
  • It covers important business models, the regulatory outlook, cost structures, and the competitive landscape.
  • Description of the top growth opportunities for the global CDSS market in the context of user relevance and calls to action has also been provided.
  • The revenue estimates in this study focus only on revenue attributed to CDSS. In some cases, such as analytics, electronic health records, and device companies, CDSS revenue represents a small part of a larger revenue stream.

The Impact of the Top 3 Strategic Imperatives on the CDSS Industry

Disruptive Technologies

WHY: The CDSS has witnessed significant advancements with the development and integration of new technologies such as AI, cloud, predictive analytics, and mobile platforms, and it will continue to impact CDSS workflows in the next few years. To achieve a highly accessible, flexible, and scalable CDSS solution, end users will continue to look for technology advancements.

FROST PERSPECTIVE: Companies need to identify new use cases and build a strong foundation of evidence-based content. The integration of dynamic AI, specifically, a combination of conversational AI and generative AI (GenAI), can empower end users with easy access to relevant information, enabling them to, for instance, create documents for administrative purposes.

Innovative Business Models

WHY: A high upfront installation and implementation cost has restrained the widespread adoption of CDSS solutions. CDSS has significant potential to improve healthcare outcomes with better clinical recommendations, ultimately benefiting patients and providers in terms of cost and resource utilization.

FROST PERSPECTIVE: Evolving business models such as software-as-a-service (SaaS), subscription models, and risk-based incentives created by technology vendors can provide flexibility in upfront investment and boost CDSS adoption. Growing awareness about the long-term benefits of improved health outcomes and economic growth will drive CDSS growth in the next few years.

Transformative Megatrends

WHY: Medical errors and staff burnout affect healthcare systems' ability to provide optimal patient care. Transitions to home care, a focus on value-based care, an increasing number of data sources, revisions of guidelines, and revenue losses also present significant challenges. Moreover, growing healthcare consumerism and a shift towards personalized care exhaust stakeholders in the face of critical decision-making moments. This is where CDSS has the biggest impact.

FROST PERSPECTIVE: This evolving market demands that vendors regularly update their products and features. Expanding offerings is critical to remaining a viable player. However, such developments cannot happen in isolation. Vendors need to include key end users and decision-makers in their research and development (R&D) programs to best target their investments toward those stakeholders' pain points. To stay ahead of the competition, companies must utilize both organic and inorganic growth pathways.

Key Competitors

  • Optum
  • EBSCO
  • Elsevier
  • Hearst Health
  • Merative
  • Medicomp Systems
  • Wolters Kluwer
  • RethinkFirst
  • Glass Health
  • UNORK
  • Premier Inc. (STANTON HEALTH)
  • Getinge
  • Motive Medical Intelligence
  • athenahealth
  • EvidenceCare
  • HCA Healthcare
  • MEDITECH
  • eClinicalWorks
  • Wolters Kluwer
  • RIMIDI
  • Inovalon
  • Vizio
  • Flatiron Health (Roche)
  • Medecision
  • MCG Health
  • Epic
  • Medical Informatics Corp.
  • Medtronic
  • Oracle Health
  • Philips Healthcare
  • GE Healthcare
  • Stat Pearls

Competitive Environment

Number of Competitors

>50 with revenue greater than $1.0 million

Competitive Factors

Cost, performance, support, technology, reliability, contractor relationships

Key End-user Industry Verticals

Providers, hospitals, primary care centers, medical devices, payers

Leading Competitors

Wolters Kluwer, Philips Healthcare, Optum, Hearst Health, Oracle Health

Revenue Share of Top 4 Competitors (2024)

18.3%

Other Notable Competitors

athenahealth, Elsevier, EBSCO, eClinicalWorks, Epic

Distribution Structure

OEMs, retail sales, direct sales, Cloud-based SaaS

Notable Acquisitions and Mergers

Health Catalyst acquired ARMUS Corporation; Oracle acquired Cerner

Growth Drivers

Value-based Care and Population Health Management: The shift towards value-based care models and population health management strategies has placed a greater emphasis on CDSS. These solutions can assist healthcare providers in identifying high-risk patients, stratifying populations, and developing targeted interventions. By supporting evidence-based decision-making, CDSS contribute to improved patient outcomes and better management of chronic conditions, aligning with the goals of value-based care.

Growing Demand for Personalized Medicine: Personalized medicine, which involves tailoring medical treatment to individual patients based on their unique characteristics, is gaining traction. CDSS can play a crucial role in facilitating personalized medicine by integrating patient-specific data, genetic information, and clinical guidelines to provide tailored recommendations. This growing demand for personalized medicine is a significant driver.

Rising Healthcare Costs and Resource Constraints: Healthcare systems worldwide are facing increasing financial pressures and resource constraints. CDSS can help optimize resource utilization by providing real-time clinical insights, reducing unnecessary tests and procedures, and improving overall efficiency. This cost-effectiveness aspect is a significant driver for the adoption of CDSS solutions.

Growth Restraints

Cost and Budgetary Constraints: Implementing and maintaining CDSS software can be costly, especially for smaller healthcare organizations or those with limited budgets. The investments in hardware, software licenses, infrastructure upgrades, and ongoing maintenance and support costs can be significant. Budgetary constraints may deter healthcare providers from adopting CDSS, especially if they perceive the benefits as uncertain or difficult to quantify.

Clinician Acceptance and Alert Fatigue: Clinicians may be skeptical of automated systems' accuracy or be concerned about a loss of autonomy. Moreover, too many or unimportant alerts may lead to alert fatigue among physicians, affecting the usage of CDSS.

System Integration Complexities: Variations in standards for healthcare records can present challenges in effective CDSS integration with existing hospital IT systems.

Table of Contents

Growth Opportunities: Research Scope

  • Scope of Analysis
  • Segmentation by Application
  • Segmentation by Region
  • Key Vendor Types

Growth Environment: Transformation in CDSS

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on the CDSS Industry

Ecosystem in CDSS

  • Competitive Environment
  • Key Competitors

Growth Generators in CDSS

  • Evolution of CDSS
  • Key Use Cases
  • Key Market Trends
  • Key Challenges and Value Proposition
  • Voice of Consumers: AI Integration in CDSS
  • Potential GenAI Use Cases in CDSS
  • Vendor Value Propositions with AI
  • Regulatory Scenario: FDA's Approach to CDSS
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Considerations
  • Revenue Forecast
  • Revenue Forecast by Application
  • Revenue Forecast Analysis
  • Pricing Trends and Forecast Analysis
  • Revenue Forecast by Region
  • Analysis of CDSS Solution Attractiveness
  • Regional Attractiveness Ranking and Mapping
  • Revenue Forecast Analysis by Region
  • Revenue Share Competitive Heatmap
  • Revenue Share Competitive Heatmap Analysis
  • Company Spotlight

Growth Generator: Decision Evidence/Protocols

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Decision Analytics

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Decision Workflow

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Generator: Decision Delivery

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: AI in CDSS
  • Growth Opportunity 2: Real-time data for Critical Conditions
  • Growth Opportunity 3: Point-of-care CDSS for Home-based Treatment

Appendix and Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • List of Exhibits
  • Legal Disclaimer